Paloma Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,744
| Closed | -$212K | – | 626 |
|
|
2024
Q3 | $212K | Buy |
+7,744
| New | +$212K | 0.01% | 685 |
|
|
2020
Q1 | – | Sell |
-16,855
| Closed | -$459K | – | 1547 |
|
|
2019
Q4 | $459K | Buy |
+16,855
| New | +$459K | 0.01% | 1191 |
|
|
2019
Q3 | – | Sell |
-8,400
| Closed | -$233K | – | 1755 |
|
|
2019
Q2 | $233K | Sell |
8,400
-11,422
| -58% | -$317K | ﹤0.01% | 1200 |
|
|
2019
Q1 | $658K | Buy |
+19,822
| New | +$658K | 0.02% | 660 |
|
|
2017
Q4 | – | Sell |
-8,200
| Closed | -$297K | – | 1492 |
|
|
2017
Q3 | $297K | Sell |
8,200
-21,421
| -72% | -$776K | ﹤0.01% | 1221 |
|
|
2017
Q2 | $766K | Sell |
29,621
-10,065
| -25% | -$260K | 0.01% | 896 |
|
|
2017
Q1 | $762K | Sell |
39,686
-9,964
| -20% | -$191K | 0.01% | 962 |
|
|
2016
Q4 | $828K | Buy |
+49,650
| New | +$828K | 0.01% | 863 |
|